我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Unleashing the Power of Pharmacogenetics: A New Era in PersonalizedMedicine

Laura Sartiani

Pharmacogenetics, the integration of genetics and pharmacology, is a rapidly advancing field with the potential to revolutionize healthcare and usher in a new era of personalized medicine. By studying how an individual’s genetic makeup influences their response to drugs, pharmacogenetics aims to optimize medication choices and dosages, maximizing efficacy while minimizing adverse reactions. This article provides an overview of pharmacogenetics, exploring its principles and mechanisms, as well as its practical applications in individualized drug selection, predicting adverse drug reactions, and dose optimization. Furthermore, it discusses the future implications of pharmacogenetics, including its integration with electronic health records, the development of novel therapies, and its potential impact on population health. Embracing pharmacogenetics has the power to transform clinical practice, leading to safer and more effective treatments tailored to each patient’s unique genetic profile.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。